CS
CHE icon

Candriam SCA’s Chemed CHE Stock Holding History

Candriam SCA’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Sell
41,398
-1,844
-4% -$775K 0.09% 205
2026
Q1 		$16.3M Sell
43,242
-12,989
-23% -$5.56M 0.08% 221
2025
Q4 		$24.1M Buy
56,231
+13,175
+31% +$5.74M 0.12% 172
2025
Q3 		$19.3M Sell
43,056
-12,553
-23% -$5.68M 0.1% 185
2025
Q2 		$27.1M Buy
55,609
+10,431
+23% +$5.94M 0.16% 124
2025
Q1 		$27.8M Buy
45,178
+30,495
+208% +$17.3M 0.17% 122
2024
Q4 		$7.78M Sell
14,683
-1,328
-8% -$749K 0.04% 298
2024
Q3 		$9.62M Buy
16,011
+6,290
+65% +$3.57M 0.06% 276
2024
Q2 		$5.27M Buy
+9,721
New +$5.57M 0.03% 336

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Candriam SCA's CHE Position: Q2 2026 in Review

Candriam SCA reduced its Chemed (CHE) stake by 4.3% in Q2 2026, selling an estimated $775K and leaving 41,398 shares worth $19.3M. The position accounts for 0.09% of the portfolio, ranked #205.

Candriam SCA first reported a position in CHE in Q2 2024 and has held it in 9 quarters since. The position peaked at $27.8M in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Candriam SCA held 41,398 shares of Chemed worth $19.3M as of Q2 2026.
  • Candriam SCA sold 1,844 Chemed shares in Q2 2026, an estimated $775K.
  • Chemed made up 0.09% of Candriam SCA's portfolio in Q2 2026, its #205 holding.
  • Candriam SCA first reported a position in Chemed in Q2 2024 and has held it in 9 quarters since.
  • Candriam SCA's Chemed position peaked at $27.8M in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.